Covid-19 Impact on Global Active Pharmaceutical Ingredients (API) Market Size, Status and Forecast 2020-2026
Table of Contents1 Study Coverage
1.1 Active Pharmaceutical Ingredients (API) Product Introduction
1.2 Market Segments
1.3 Key Active Pharmaceutical Ingredients (API) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type
1.4.2 Synthetic APIs
1.4.3 Biotech APIs
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application
1.5.2 CNS
1.5.3 Cardiovascular
1.5.4 Genitourinary/Hormonal Drugs
1.5.5 Respiratory
1.5.6 Rheumatology
1.5.7 Diabetes
1.5.8 Oncology
1.5.9 Others
1.6 Coronavirus Disease 2019 (Covid-19): Active Pharmaceutical Ingredients (API) Industry Impact
1.6.1 How the Covid-19 is Affecting the Active Pharmaceutical Ingredients (API) Industry
1.6.1.1 Active Pharmaceutical Ingredients (API) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Active Pharmaceutical Ingredients (API) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Active Pharmaceutical Ingredients (API) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts
2.1.1 Global Active Pharmaceutical Ingredients (API) Revenue 2015-2026
2.1.2 Global Active Pharmaceutical Ingredients (API) Sales 2015-2026
2.2 Active Pharmaceutical Ingredients (API) Market Size by Region: 2020 Versus 2026
2.2.1 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Active Pharmaceutical Ingredients (API) Competitor Landscape by Players
3.1 Active Pharmaceutical Ingredients (API) Sales by Manufacturers
3.1.1 Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2015-2020)
3.1.2 Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2015-2020)
3.2 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers
3.2.1 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2015-2020)
3.2.2 Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Active Pharmaceutical Ingredients (API) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients (API) Revenue in 2019
3.2.5 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Active Pharmaceutical Ingredients (API) Price by Manufacturers
3.4 Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Product Types
3.4.1 Active Pharmaceutical Ingredients (API) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharmaceutical Ingredients (API) Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)
4.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020)
4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type (2015-2020)
4.1.3 Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Active Pharmaceutical Ingredients (API) Market Size Forecast by Type (2021-2026)
4.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2021-2026)
4.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2021-2026)
4.2.3 Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Active Pharmaceutical Ingredients (API) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)
5.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020)
5.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application (2015-2020)
5.1.3 Active Pharmaceutical Ingredients (API) Price by Application (2015-2020)
5.2 Active Pharmaceutical Ingredients (API) Market Size Forecast by Application (2021-2026)
5.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2021-2026)
5.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2021-2026)
5.2.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Active Pharmaceutical Ingredients (API) by Country
6.1.1 North America Active Pharmaceutical Ingredients (API) Sales by Country
6.1.2 North America Active Pharmaceutical Ingredients (API) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
6.3 North America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
7 Europe
7.1 Europe Active Pharmaceutical Ingredients (API) by Country
7.1.1 Europe Active Pharmaceutical Ingredients (API) Sales by Country
7.1.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
7.3 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Active Pharmaceutical Ingredients (API) by Region
8.1.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region
8.1.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
8.3 Asia Pacific Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Active Pharmaceutical Ingredients (API) by Country
9.1.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Country
9.1.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
9.3 Central & South America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Active Pharmaceutical Ingredients (API) by Country
10.1.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country
10.1.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
10.3 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description, Business Overview and Total Revenue
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
11.1.5 Teva Recent Development
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Description, Business Overview and Total Revenue
11.2.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mylan Active Pharmaceutical Ingredients (API) Products Offered
11.2.5 Mylan Recent Development
11.3 DSM
11.3.1 DSM Corporation Information
11.3.2 DSM Description, Business Overview and Total Revenue
11.3.3 DSM Sales, Revenue and Gross Margin (2015-2020)
11.3.4 DSM Active Pharmaceutical Ingredients (API) Products Offered
11.3.5 DSM Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Corporation Information
11.4.2 Aurobindo Pharma Description, Business Overview and Total Revenue
11.4.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Products Offered
11.4.5 Aurobindo Pharma Recent Development
11.5 Aspen
11.5.1 Aspen Corporation Information
11.5.2 Aspen Description, Business Overview and Total Revenue
11.5.3 Aspen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aspen Active Pharmaceutical Ingredients (API) Products Offered
11.5.5 Aspen Recent Development
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description, Business Overview and Total Revenue
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Active Pharmaceutical Ingredients (API) Products Offered
11.6.5 Novartis Recent Development
11.7 BASF
11.7.1 BASF Corporation Information
11.7.2 BASF Description, Business Overview and Total Revenue
11.7.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BASF Active Pharmaceutical Ingredients (API) Products Offered
11.7.5 BASF Recent Development
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description, Business Overview and Total Revenue
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Active Pharmaceutical Ingredients (API) Products Offered
11.8.5 Pfizer Recent Development
11.9 Huahai Pharmaceutical
11.9.1 Huahai Pharmaceutical Corporation Information
11.9.2 Huahai Pharmaceutical Description, Business Overview and Total Revenue
11.9.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
11.9.5 Huahai Pharmaceutical Recent Development
11.10 Hisun Pharmaceutical
11.10.1 Hisun Pharmaceutical Corporation Information
11.10.2 Hisun Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Hisun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
11.10.5 Hisun Pharmaceutical Recent Development
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description, Business Overview and Total Revenue
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
11.1.5 Teva Recent Development
11.12 Zhejiang Medicine
11.12.1 Zhejiang Medicine Corporation Information
11.12.2 Zhejiang Medicine Description, Business Overview and Total Revenue
11.12.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Zhejiang Medicine Products Offered
11.12.5 Zhejiang Medicine Recent Development
11.13 Dr. Reddy's Laboratories
11.13.1 Dr. Reddy's Laboratories Corporation Information
11.13.2 Dr. Reddy's Laboratories Description, Business Overview and Total Revenue
11.13.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Dr. Reddy's Laboratories Products Offered
11.13.5 Dr. Reddy's Laboratories Recent Development
11.14 Zhejiang NHU
11.14.1 Zhejiang NHU Corporation Information
11.14.2 Zhejiang NHU Description, Business Overview and Total Revenue
11.14.3 Zhejiang NHU Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Zhejiang NHU Products Offered
11.14.5 Zhejiang NHU Recent Development
11.15 Bayer
11.15.1 Bayer Corporation Information
11.15.2 Bayer Description, Business Overview and Total Revenue
11.15.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Bayer Products Offered
11.15.5 Bayer Recent Development
11.16 NCPC
11.16.1 NCPC Corporation Information
11.16.2 NCPC Description, Business Overview and Total Revenue
11.16.3 NCPC Sales, Revenue and Gross Margin (2015-2020)
11.16.4 NCPC Products Offered
11.16.5 NCPC Recent Development
11.17 AbbVie
11.17.1 AbbVie Corporation Information
11.17.2 AbbVie Description, Business Overview and Total Revenue
11.17.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.17.4 AbbVie Products Offered
11.17.5 AbbVie Recent Development
11.18 Shandong Xinhua Pharmaceutical
11.18.1 Shandong Xinhua Pharmaceutical Corporation Information
11.18.2 Shandong Xinhua Pharmaceutical Description, Business Overview and Total Revenue
11.18.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Shandong Xinhua Pharmaceutical Products Offered
11.18.5 Shandong Xinhua Pharmaceutical Recent Development
11.19 Northeast Pharm
11.19.1 Northeast Pharm Corporation Information
11.19.2 Northeast Pharm Description, Business Overview and Total Revenue
11.19.3 Northeast Pharm Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Northeast Pharm Products Offered
11.19.5 Northeast Pharm Recent Development
11.20 Harbin Pharmaceutical
11.20.1 Harbin Pharmaceutical Corporation Information
11.20.2 Harbin Pharmaceutical Description, Business Overview and Total Revenue
11.20.3 Harbin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Harbin Pharmaceutical Products Offered
11.20.5 Harbin Pharmaceutical Recent Development
11.21 LKPC
11.21.1 LKPC Corporation Information
11.21.2 LKPC Description, Business Overview and Total Revenue
11.21.3 LKPC Sales, Revenue and Gross Margin (2015-2020)
11.21.4 LKPC Products Offered
11.21.5 LKPC Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Active Pharmaceutical Ingredients (API) Market Estimates and Projections by Region
12.1.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Regions 2021-2026
12.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions 2021-2026
12.2 North America Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.2.1 North America: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.2.2 North America: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.2.3 North America: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)
12.3 Europe Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.3.1 Europe: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.3.2 Europe: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.3.3 Europe: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Active Pharmaceutical Ingredients (API) Market Size Forecast by Region (2021-2026)
12.5 Latin America Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.5.1 Latin America: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.5.2 Latin America: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.5.3 Latin America: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Active Pharmaceutical Ingredients (API) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharmaceutical Ingredients (API) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of TablesTable 1. Active Pharmaceutical Ingredients (API) Market Segments
Table 2. Ranking of Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Synthetic APIs
Table 5. Major Manufacturers of Biotech APIs
Table 6. COVID-19 Impact Global Market: (Four Active Pharmaceutical Ingredients (API) Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Active Pharmaceutical Ingredients (API) Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Active Pharmaceutical Ingredients (API) Players to Combat Covid-19 Impact
Table 11. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Active Pharmaceutical Ingredients (API) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Active Pharmaceutical Ingredients (API) Sales by Regions 2015-2020 (K MT)
Table 14. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Regions (2015-2020)
Table 15. Global Active Pharmaceutical Ingredients (API) Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2015-2020)
Table 18. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2019)
Table 20. Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Active Pharmaceutical Ingredients (API) Price (2015-2020) (USD/MT)
Table 23. Active Pharmaceutical Ingredients (API) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 25. Date of International Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 28. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2015-2020)
Table 29. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2015-2020)
Table 31. Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 33. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2015-2020)
Table 34. North America Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)
Table 35. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)
Table 36. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)
Table 38. North America Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 39. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 40. North America Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 41. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 42. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)
Table 43. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)
Table 44. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)
Table 46. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 47. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 48. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 49. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 58. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)
Table 59. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)
Table 62. Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 63. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 64. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 65. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 74. Teva Corporation Information
Table 75. Teva Description and Major Businesses
Table 76. Teva Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Teva Product
Table 78. Teva Recent Development
Table 79. Mylan Corporation Information
Table 80. Mylan Description and Major Businesses
Table 81. Mylan Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Mylan Product
Table 83. Mylan Recent Development
Table 84. DSM Corporation Information
Table 85. DSM Description and Major Businesses
Table 86. DSM Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. DSM Product
Table 88. DSM Recent Development
Table 89. Aurobindo Pharma Corporation Information
Table 90. Aurobindo Pharma Description and Major Businesses
Table 91. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Aurobindo Pharma Product
Table 93. Aurobindo Pharma Recent Development
Table 94. Aspen Corporation Information
Table 95. Aspen Description and Major Businesses
Table 96. Aspen Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Aspen Product
Table 98. Aspen Recent Development
Table 99. Novartis Corporation Information
Table 100. Novartis Description and Major Businesses
Table 101. Novartis Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Novartis Product
Table 103. Novartis Recent Development
Table 104. BASF Corporation Information
Table 105. BASF Description and Major Businesses
Table 106. BASF Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. BASF Product
Table 108. BASF Recent Development
Table 109. Pfizer Corporation Information
Table 110. Pfizer Description and Major Businesses
Table 111. Pfizer Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Pfizer Product
Table 113. Pfizer Recent Development
Table 114. Huahai Pharmaceutical Corporation Information
Table 115. Huahai Pharmaceutical Description and Major Businesses
Table 116. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Huahai Pharmaceutical Product
Table 118. Huahai Pharmaceutical Recent Development
Table 119. Hisun Pharmaceutical Corporation Information
Table 120. Hisun Pharmaceutical Description and Major Businesses
Table 121. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Hisun Pharmaceutical Product
Table 123. Hisun Pharmaceutical Recent Development
Table 124. Sun Pharmaceutical Industries Corporation Information
Table 125. Sun Pharmaceutical Industries Description and Major Businesses
Table 126. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Sun Pharmaceutical Industries Product
Table 128. Sun Pharmaceutical Industries Recent Development
Table 129. Zhejiang Medicine Corporation Information
Table 130. Zhejiang Medicine Description and Major Businesses
Table 131. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Zhejiang Medicine Product
Table 133. Zhejiang Medicine Recent Development
Table 134. Dr. Reddy's Laboratories Corporation Information
Table 135. Dr. Reddy's Laboratories Description and Major Businesses
Table 136. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Dr. Reddy's Laboratories Product
Table 138. Dr. Reddy's Laboratories Recent Development
Table 139. Zhejiang NHU Corporation Information
Table 140. Zhejiang NHU Description and Major Businesses
Table 141. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Zhejiang NHU Product
Table 143. Zhejiang NHU Recent Development
Table 144. Bayer Corporation Information
Table 145. Bayer Description and Major Businesses
Table 146. Bayer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Bayer Product
Table 148. Bayer Recent Development
Table 149. NCPC Corporation Information
Table 150. NCPC Description and Major Businesses
Table 151. NCPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. NCPC Product
Table 153. NCPC Recent Development
Table 154. AbbVie Corporation Information
Table 155. AbbVie Description and Major Businesses
Table 156. AbbVie Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. AbbVie Product
Table 158. AbbVie Recent Development
Table 159. Shandong Xinhua Pharmaceutical Corporation Information
Table 160. Shandong Xinhua Pharmaceutical Description and Major Businesses
Table 161. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Shandong Xinhua Pharmaceutical Product
Table 163. Shandong Xinhua Pharmaceutical Recent Development
Table 164. Northeast Pharm Corporation Information
Table 165. Northeast Pharm Description and Major Businesses
Table 166. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Northeast Pharm Product
Table 168. Northeast Pharm Recent Development
Table 169. Harbin Pharmaceutical Corporation Information
Table 170. Harbin Pharmaceutical Description and Major Businesses
Table 171. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Harbin Pharmaceutical Product
Table 173. Harbin Pharmaceutical Recent Development
Table 174. LKPC Corporation Information
Table 175. LKPC Description and Major Businesses
Table 176. LKPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 177. LKPC Product
Table 178. LKPC Recent Development
Table 179. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Regions (2021-2026) (K MT)
Table 180. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Regions (2021-2026)
Table 181. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 182. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Regions (2021-2026)
Table 183. North America: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)
Table 184. North America: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Europe: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)
Table 186. Europe: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Asia Pacific: Active Pharmaceutical Ingredients (API) Sales Forecast by Region (2021-2026) (K MT)
Table 188. Asia Pacific: Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 189. Latin America: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)
Table 190. Latin America: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 191. Middle East and Africa: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)
Table 192. Middle East and Africa: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)
T